NOT-CA-20-085: Pre-Application Webinar for RFA-CA-20-042, 3D Technologies to Accelerate HTAN Atlas Building Efforts (UH2 Clinical Trial Not Allowed)

Pre-Application Webinar for RFA-CA-20-042, 3D Technologies to Accelerate HTAN Atlas Building Efforts (UH2 Clinical Trial Not Allowed)

Notice Number:

NOT-CA-20-085

Key Dates

Release Date:

July 14, 2020

Related Announcements

RFA-CA-20-042 - 3D Technologies to Accelerate HTAN Atlas Building Efforts (UH2 Clinical Trial Not Allowed)

Issued by

National Cancer Institute (NCI)

Purpose

The NCI will hold a pre-application webinar on Friday, August 21, 2020, from 2:00 - 3:00 PM (EDT) for the Funding Opportunity Announcement (FOA) RFA-CA-20-042 entitled "3D Technologies to Accelerate HTAN Atlas Building Efforts (UH2 Clinical Trial Not Allowed)”.

NCI staff members involved in the FOA will provide a brief overview of the above-referenced FOA for potential applicants by explaining the goals and objectives for the FOA, as well as answering questions from webinar attendees. Please submit questions by August 19, 2020 to [email protected]. Attendees will also be able to submit questions during the webinar. Questions submitted early will be answered first.

To join the webinar, pre-registration is required through Webex: https://cbiit.webex.com/cbiit/j.php?RGID=rc71f89b5dcb07b10e0162b2c47f53b35. Specific webinar information will be provided upon registration.

Participation in this webinar, although encouraged, is optional and is not required for the submission of an application in response to RFA-CA-20-042. A document highlighting frequently asked questions and corresponding answers will be posted to the HTAN website following the webinar.

Inquiries

Please direct all inquiries to:

Philipp Oberdoerffer, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-760-6681
Email:[email protected]